In this study, we aimed to evaluate and compare the expression status of CLDN gene family members (CLDN1-4,7,8,10,14,16,18,19), which are responsible for the mechanism of stone formation, in patients with recurrent calcium oxalate kidney stones and in controls presenting to our clinic with complaints other than kidney stones. This evidence concerns the gene CLDN1 and nephrolithiasis.